Betekenis van:
serum disease

serum disease
Zelfstandig naamwoord
    • a delayed allergic reaction to the injection of an antiserum caused by an antibody reaction to an antigen in the donor serum

    Synoniemen

    Hyperoniemen


    Voorbeeldzinnen

    1. Blood counts and screening for disease parasites Blood, clotted (serum)
    2. the donor females underwent a serum neutralisation test for Akabane disease, carried out on a blood sample taken not less than 21 days following their collection (1) and giving negative results;
    3. the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to a serum neutralisation test for Akabane disease carried out with negative results on a blood sample taken not less than 21 days following collection (1).
    4. the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno-diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);
    5. the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno-diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);
    6. the animals have been subjected with negative results to a serum neutralisation or approved ELISA test for antibody against Hendra and Nipah disease viruses, carried out in a laboratory approved for these tests by the competent authorities on samples of blood taken on two occasions with an interval of 21 to 30 days, the second sample to be taken within 10 days of export.
    7. the donor females and donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to a serum neutralisation test for Akabane disease carried out with negative results on a blood sample taken not less than 21 days following collection (1).
    8. the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected to an agar gel immuno diffusion test and a serum neutralisation test for the detection of antibodies against the epizootic haemorrhagic disease virus carried out with negative results on a blood sample taken not less than 21 days following collection (1);
    9. the donors of the oocytes used in the production of the embryos underwent a serum neutralisation test for Akabane disease giving negative results, carried out on a blood sample taken not less than 21 days following their collection, or an agent identification test carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of slaughtering (1);
    10. the donors of the oocytes used in the production of embryos underwent a serum neutralisation test for Akabane disease giving negative results and carried out on a blood sample taken not less than 21 days following their collection, or an agent identification test carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of slaughtering (1);
    11. has not been free from foot-and-mouth disease for the 12 months immediately prior to the collection of the embryos and/or practises vaccination against it and the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos come from a holding in which no animal has been vaccinated against foot-and-mouth disease during the 30 days prior to collection, and the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection; 11.2.3. either (1): has been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection of the embryos to be exported and does not practise vaccination against them or 11.2.3.2. has not been free from bluetongue and epizootic haemorrhagic disease (EHD) for the 12 months immediately prior to collection of the embryos to be exported and/or practises vaccination against them and the embryos have been stored in approved conditions for a minimum period of 30 days immediately after collection, and the donor females and the donors of ovaries, oocytes and other tissues used in the production of embryos were subjected with negative results to an agar gel immuno diffusion test and a serum neutralisation test for epizootic haemorrhagic disease antibodies on a blood sample taken not less than 21 days following collection.11.3.
    12. which were subjected in an approved laboratory with negative results prior to entry and every six months to an agar-gel immuno-diffusion test (4) and a virus neutralization test for all serotypes of epizootic haemorrhagic disease (EHD) known to exist in the exporting country, which are the following: ;**11.5.6. which were subjected on two occasions not more than 12 months apart to the following pre-collection and post-collection tests with negative results in an approved laboratory (the post-collection test must be performed on a blood sample taken not less than 21 days following the collection of semen for export) to a serum neutralisation test for Akabane virus;*11.6. the semen to be exported was collected after the date of approval of the centre by the competent national authorities of the exporting country;11.7. The semen to be exported was processed, stored and transported under conditions, which satisfy the terms of Directive 88/407/EEC.E.
    13. which were subjected in an approved laboratory with negative results prior to entry and every six months to an agar-gel immuno-diffusion test (4) and a virus neutralization test for all serotypes of epizootic haemorrhagic disease (EHD) known to exist in the exporting country, which are the following: ;**11.5.6. which were subjected on two occasions not more than 12 months apart to the following pre-collection and post-collection tests with negative results in an approved laboratory (the post-collection test must be performed on a blood sample taken not less than 21 days following the collection of semen for export) to a serum neutralisation test for Akabane virus;*11.6. the semen to be exported was collected after the date of approval of the centre by the competent national authorities of the exporting country;11.7.